Rahsaan Thompson is EVP and General Counsel of Gritstone bio, Inc.. Currently has a direct ownership of 58,698 shares of GRTS, which is worth approximately $1,173. The most recent transaction as insider was on Jan 31, 2022, when has been sold 19,240 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 58.7K
0% 3M change
0% 12M change
Total Value Held $1,173

Rahsaan Thompson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 31 2022
BUY
Grant, award, or other acquisition
-
19,240 Added 24.69%
58,698 Common Stock
Jan 07 2021
BUY
Grant, award, or other acquisition
-
25,500 Added 46.37%
29,487 Common Stock

Also insider at

LYEL
Lyell Immunopharma, Inc. Healthcare
KMPH
KEMPHARM, INC Healthcare
RT

Rahsaan Thompson

EVP and General Counsel
Emeryville, CA

Track Institutional and Insider Activities on GRTS

Follow Gritstone bio, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GRTS shares.

Notify only if

Insider Trading

Get notified when an Gritstone Bio, Inc. insider buys or sells GRTS shares.

Notify only if

News

Receive news related to Gritstone bio, Inc.

Track Activities on GRTS